Andre Lamy, John Eikelboom, Tej Sheth, Stuart Connolly, Jackie Bosch, Keith A A Fox, Jun Zhu, Eva Lonn, Gilles Dagenais, Petr Widimsky, Kelly R H Branch, Deepak L Bhatt, Zhe Zheng, Zbynek Straka, Francois Dagenais, Ye Kong, Tamara Marsden, Shun Fu Lee, Ingrid Copland, Salim Yusuf
BACKGROUND: Patients with recent coronary artery bypass graft (CABG) surgery are at risk for early graft failure, which is associated with a risk of myocardial infarction and death. In the COMPASS (Cardiovascular OutcoMes for People Using Anticoagulation StrategieS) trial, rivaroxaban 2.5 mg twice daily plus aspirin 100 mg once daily compared with aspirin 100 mg once daily reduced the primary major adverse cardiovascular events (MACE) outcome of cardiovascular death, stroke, or myocardial infarction...
January 22, 2019: Journal of the American College of Cardiology